List of Figures
Summary Figure : Global Market for Cell Culture, by Segment, 2020-2025
Figure 1 : Research Chain for Cell Culture
Figure 2 : A Model for The Evolution of FDA Regulation
Figure 3 : An Innovation Matrix
Figure 4 : Bioprinting Strategic Roadmap
Figure 5 : Gastrointestinal Organotype Cultures
Figure 6 : iCELLis Nanoreactor: Example of Commercial 2D Cell Culture Systems
Figure 7 : Prototype of 3D Model Lung-on-a-Chip from Wake Forest
Figure 8 : Recent Photos of the HepaChip
Figure 9 : Recent Photos of the HepaChip-MWP
Figure 10 : University of Toronto Handheld Bioprinting Device
Figure 11 : Collaborative Experiment Conducted by American, Russian and Israeli Scientists
Figure 12 : Smart Marbles Concept for Quantifying Process Heterogeneity
Figure 13 : Porcine Intestinal Organoids
Figure 14 : Diagram of the Components of a Predictive Toxicology System
Figure 15 : Gleason’s Pattern
Figure 16 : Diagram of PDXs, Cell Lines and Organoid/Spheroid Xenografts
Figure 17 : Cell Heterogeneity and Its Function
Figure 18 : Electron Micrograph of Porous Microcarrier for Stem Cell Production
Figure 19 : Photograph of Apligraf

 

List of Tables
Summary Table : Global Market for Cell Culture, by Segment, Through 2025
Table 1 : Dimensionality of Cell Culture
Table 2 : WHO R&D Roadmap of Priority Infectious Diseases
Table 3 : 3D Bioprinting Roadmap
Table 4 : Selected Online Prices for Bioreactors
Table 5 : Current Clinical Trials on Remdesivir
Table 6 : Tissue Types
Table 7 : Cell Types Based on Developmental Origin
Table 8 : Leading Cell Line Suppliers, April 2020
Table 9 : Commonly Used Transformed Cells Lines
Table 10 : Major Primary Cell Lines
Table 11 : Leading Primary Cell Suppliers, April 2020
Table 12 : Main Types of Stem Cells
Table 13 : Stem Cell Services
Table 14 : Areas of Interest in 3D Spheroid Research
Table 15 : Global Market for Cell Culture Consumables in Research, Through 2025
Table 16 : Selected Nanoparticle Products Used in Life Science Research
Table 17 : Results of Liver-Chip Drugs Halted in Previous Clinical Trials Based on Animal Studies
Table 18 : Companies and Universities Involved in the Organ-on-a-Chip Industry
Table 19 : Global Market for Cell Culture Equipment, by Type, Through 2025
Table 20 : Microfluidics Companies
Table 21 : Selected Recent Patents Issued on Microfluidic Devices Related to Cell Culture Applications
Table 22 : Selected Papers Published on Recent Microfluidic Advances in Cell Culture
Table 23 : High-Content Screening Suppliers and Key Attributes, April 2020
Table 24 : Selected Patents Issued Related to Flow Cytometers
Table 25 : Thermo Fisher Imaging Products
Table 26 : Publicly Disclosed Funding of Bioprinting Companies, 2017-2020*
Table 27 : Bioprinting Company Deals and Strategic Partnerships, 2019 and 2020
Table 28 : Bioprinting Modalities
Table 29 : Maintaining Cell Viability During Printing
Table 30 : Bioprinting Instrument Industry
Table 31 : Biomaterial Components
Table 32 : Bioink Types
Table 33 : Classes of Matrix Bioink Hydrogels
Table 34 : Matrix Bioink Selection Criteria
Table 35 : Selected Bioink Companies, 2020
Table 36 : Projected Unit Sales of Research Bioreactors, <10 Liters, 2020
Table 37 : Leading Bioreactor Suppliers, 2020
Table 38 : Label-Free Technologies and Suppliers, April 2020
Table 39 : Global Market for Software and Services for Cell Culture Research, Through 2025
Table 40 : Global Market for Bioprocessing Consumables for Cell Culture, Through 2025
Table 41 : Global Market for Cell Culture Bioprocessing Equipment, by Type, Through 2025
Table 42 : Global Market for Software for Cell Culture in Bioprocessing, Through 2025
Table 43 : Developmental Issues Facing the Commercialization of Exosomes
Table 44 : Companies Working on Exosome Products
Table 45 : Global Market for Cell Culture, by End User, Through 2025
Table 46 : Global Market for Cell Culture, by Application, Through 2025
Table 47 : Global Market for Cell Culture, by Region, Through 2025
Table 48 : Typical Assay Endpoints and Tests
Table 49 : U.S. Patents on Assays Systems, 2019 and 2020
Table 50 : Selected U.S. Patents on Assay Imaging, 2019 and 2020
Table 51 : Recently Issued U.S. Patents on Cellomics, 2017-2019
Table 52 : Toxicology Issues That Need to Be Addressed for FDA-Regulated Products
Table 53 : Overview of Federal Regulation of the Cell Culture Markets
Table 54 : FDA List of Cell, Biologic and Tissue Products Regulated Under CBER and CDRH
Table 55 : FDA “Talking Point” Recommendations for Regenerative Medicine Advanced Therapies (RMATs)
Table 56 : U.S. Regulatory Considerations
Table 57 : Main Types of Models for Researching Cancer and Other Diseases
Table 58 : Goals of Funding Opportunity Announcement RFA-CA-19-055
Table 59 : Common 3D Assays
Table 60 : 3D Tumor Models Developed for Drug Discovery, June 2017
Table 61 : Summary of the Benefits and Advantages of EV3D
Table 62 : ECVAM List of Current Activities, 2020
Table 63 : In Vitro Testing in Cosmetics, by Test Class
Table 64 : In Vitro and In Vivo Assays in the Tier 1 Screening Battery, January 2014
Table 65 : Timeline of Key Developments in Stem Cell Research, 1978-2006
Table 66 : Major and Minor Research Areas in Stem Cells
Table 67 : Stem Cell Usage in Research
Table 68 : Recent U.S. Patents Granted on Stem Cell Technologies
Table 69 : Papers Published on Selected Stem Cell Research Trends
Table 70 : Comparison of the Number of Citations in the Literature on Cell Culture versus Stem Cell Culture
Table 71 : Number of Organ Transplants Performed in the United States, 2018 and 2019
Table 72 : Total Global Financing of Regenerative Medicine
Table 73 : Total Financing of Regenerative Medicine, by Therapeutic Area
Table 74 : Leading Tissue Products and Suppliers, April 2020
Table 75 : Printed Tissue and Organs: Commercialization Timeframe
Table 76 : Tissue/Organ Complexity
Table 77 : New Bioassay Kits Introduced by BioVision
Table 78 : Partial List of Specialty Media Formulations Sold by Cell Applications Inc.